The Paths to Approvals of Therapeutics and Diagnostics at the FDA in the Era of Personalized Medicine and the 21st Century Cures Legislation
Jan 31, 2017
from 12:00 PM to 01:00 PM
|Where||6th floor Amphitheater, UPR-MSC Main Building, UPR-Medical Sciences Campus|
|Add event to calendar||
Federico Goodsaid, Ph.D.
Vice President of Assay Development and Regulatory Affairs
TOMA Biosciences, Foster City, CA
This seminar series is supported by an NIGMS INBRE grant P20 GM103475 in collaboration with UPR-SOM Biomedical Sciences Graduate Program, Puerto Rico Clinical and Translational Research Consortium TRCL (U54 MD007587) and RCMI CGHDRD (G12 MD007600).